Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized double-blinded clinical trial to support interchangeability
- DOI
- 10.1093/bjd/ljag218
- Published
- 2026-05-29
- Container
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/bjd/ljag218,
title = {Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized double-blinded clinical trial to support interchangeability},
author = {Andrew Blauvelt and Jerry Bagel and Andreas Pinter and Diamant Thaçi and Muhan Zhou and Jia Cao and Daniel T Mytych and Vincent Chow and Janet Franklin},
year = {2026},
journal = {British Journal of Dermatology},
doi = {10.1093/bjd/ljag218},
url = {https://doi.org/10.1093/bjd/ljag218}
}RIS
TY - JOUR TI - Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized double-blinded clinical trial to support interchangeability AU - Andrew Blauvelt AU - Jerry Bagel AU - Andreas Pinter AU - Diamant Thaçi AU - Muhan Zhou AU - Jia Cao AU - Daniel T Mytych AU - Vincent Chow AU - Janet Franklin PY - 2026 JO - British Journal of Dermatology DO - 10.1093/bjd/ljag218 UR - https://doi.org/10.1093/bjd/ljag218 ER -
APA
Blauvelt, A., Bagel, J., Pinter, A., Thaçi, D., Zhou, M., Cao, J., Mytych, D. T., Chow, V., & Franklin, J. (2026). Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized double-blinded clinical trial to support interchangeability. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljag218
Source records
- crossref · retrieved 2026-09-26T07:54:28.798Z